HomeLatest ThreadsGreatest ThreadsForums & GroupsMy SubscriptionsMy Posts
DU Home » Latest Threads » Forums & Groups » Main » Editorials & Other Articles (Forum) » Medical Research? Congres...

Sun Jan 7, 2018, 08:43 AM

Medical Research? Congress Cheers. Medical Care? Congress Brawls. NYT, Jan. 5, 18

- Medical Research? Congress Cheers. Medical Care? Congress Brawls, The New York Times, Jan. 6, 2018

WASHINGTON — They cannot agree on subsidies for low-income people under the Affordable Care Act or even how to extend funding for the broadly popular Children’s Health Insurance Program — two issues requiring urgent attention as Congress returns to work.
But a more exotic corner of the medical world has drawn rapturous agreement among Republicans and Democrats: the development of new treatments and cures through taxpayer-funded biomedical research.
For the third straight year, lawmakers are planning to increase the budget of the National Institutes of Health by $2 billion. In the process, they have summarily rejected cuts proposed by President Trump.

The push for additional funding reflects a fascination among legislators with advances in fields like molecular biology, genetics and regenerative medicine, even as they wage bitter battles over just how large a role the government should play in financing health care and providing coverage. At a recent hearing, Senators Lamar Alexander of Tennessee and Tim Scott of South Carolina, both Republicans, and Maggie Hassan of New Hampshire, a Democrat, pressed scientists to explain exactly how gene editing technology could lead to new treatments for sickle cell anemia, H.I.V., cystic fibrosis, Alzheimer’s and other diseases.

Ms. Hassan wanted to know the relative merits of different techniques for editing DNA and RNA — what she called “this incredible cutting-edge technology.” Why is medical research so much less contentious than fundamental issues like health insurance coverage?
Anthony J. Mazzaschi, a lobbyist at the national organization representing schools of public health, said “the charisma of the cure, the hope and promise of curing disease, seems to excite members of Congress,” including some in their 70s and 80s who are “facing the prospect of disease and disability head-on.” And that prospect is bipartisan. “Disease doesn’t impact just Republicans or Democrats,” said Representative Diana DeGette, Democrat of Colorado. “It impacts everybody.”

While the search for new treatments and cures is advancing at breakneck speed, ideas about how to help patients pay for them lag far behind. And Republicans who sometimes laud the N.I.H. as the National Institutes of Hope also support dismantling the Affordable Care Act, which could limit access to the new treatments.
“If we are spending billions to incentivize the development of new drugs, I think we also have to ensure that patients can afford those drugs,” said Representative Jan Schakowsky, Democrat of Illinois. “It is almost cruel to find a cure and then have it priced so high that a patient can’t afford it.”
The challenges facing patients and policymakers were illustrated this past week when a Philadelphia company said it would charge $850,000 for a new gene therapy to treat a rare inherited form of blindness. (The company, Spark Therapeutics, said it would pay rebates to certain insurers if the medicine, given in a one-time injection, did not work as promised.)
Members of Congress have friends, relatives and constituents who suffer from cancer, Alzheimer’s and other diseases, but lawmakers may have less interaction with people who are uninsured and unable to afford doctor visits or prescription drugs.

More, https://www.msn.com/en-us/news/politics/medical-research-congress-cheers-medical-care-congress-brawls/ar-BBHWlNN?li=BBnb7Kz

0 replies, 932 views

Reply to this thread

Back to top Alert abuse

Reply to this thread